Send feedback

SCRIB p.Asp260=

c.780C>T · VCV4901841

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00446%, eas)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -13GERP -3.6
Overall
CADD0.019PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00446% East Asian · 2/44,838 alleles
Filtering AF 0.000739% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000277%
Overall 0.00119% 19/1,599,716 alleles · very rare exomes 13/1,447,356 · genomes 6/152,360 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 0.11% 912
Remaining individualsnot grpmax-eligible 0.00481% 20,783
East Asiangrpmax 0.00446% 22,419
African / African-American 0.00267% 37,514
Finnishnot grpmax-eligible 0.00194% 51,434
Admixed American 0.00167% 59,974
European (non-Finnish) 0.000764% 130,950

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SCRIB
Protein
p.Asp260=
Coding
c.780C>T
MANE Select
NM_182706
Type
single nucleotide variant
Location
chr8:143812824 (GRCh38)
Gene constraint
LOEUF 0.684 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 52.33 · 42 PDB
Residue 260
the 'sufficient for targeting to adherens junction and to inhibit cell proliferation' region
Full SCRIB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scrib-p-asp260 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown